Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

'Right To Try' Bill Contradicts US FDA’s Mission, Former Official Says

Mar 14 2017

• By Kate Rawson

FDA entrance sign 2016

Related Content

Expanded Access Programs Need FDA Policy Changes To Really Expand

May 23 2016

Jenkins' Retirement From US FDA Was Several Years In The Making

Dec 06 2016

Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process

Mar 13 2017

Biogen Spinraza Approval: The Perfect Antidote To Sarepta Headlines?

Jan 07 2017

'Right to Try' Has White House Support: Add-On To PDUFA Looks Tough To Stop

Feb 10 2017

'Right To Try' Or 'Right To Ask'? Hearing Spotlights Adverse Events As Key Barrier To Expanded Access

Sep 26 2016

Additional Topics

United States Legislation Policy FDA BioPharmaceutical

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window